Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01253759 · ClinicalTrials.gov registry record
Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Therapy (PDT) in Choroidal Melanoma
A clinical trial, sponsored by New England Retina Associates.
- Completed
- Registry status
- 46
- Enrollment target
NCT01253759: Completed study, sponsored by New England Retina Associates.
NCT01253759 is a clinical trial that has completed, run by New England Retina Associates. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01253759 has completed, sponsored by New England Retina Associates.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
This is a report of 10 years results of combined Transpupillary thermotherapy (TTT) treatment with Indocyanine green (ICG) in controlling small and medium-sized choroidal melanomas.
Interventions
- PROCEDURE TTT + ICG-based PDT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-03 |
What the finished NCT01253759 record still lists
NCT01253759 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which TTT + ICG-based PDT is the first listed.
NCT01253759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01253759 about?
NCT01253759 is a clinical study titled "Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Therapy (PDT) in Choroidal Melanoma". This is a report of 10 years results of combined Transpupillary thermotherapy (TTT) treatment with Indocyanine green (ICG) in controlling small and medium-sized choroidal melanomas.
What is the current status of trial NCT01253759?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2009-01. Estimated completion is 2009-03.
What interventions are being tested in trial NCT01253759?
The interventions under investigation include: TTT + ICG-based PDT (PROCEDURE).
Who is sponsoring clinical trial NCT01253759?
This trial is sponsored by New England Retina Associates, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia